Study of NKTR 255 in Combination With Cetuximab in Solid Tumors
Clinical trial NCT04616196 · COMPLETED
Trial details
- NCT number
- NCT04616196
- Sponsor
- Nektar Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2023-03-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.